Company: BIAF
Filing Date: 2025-09-16
Form Type: CORRESP
Source: 0001493152-25-013610
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-09-16
Form: CORRESP
Chunk 0
---
<div align='center'>bioAffinity Technologies, Inc.

3300 Nacogdoches Road, Suite 216

San Antonio, Texas 78217

(210) 698-5334</div>

September 16, 2025

VIA EDGAR

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Robert Augustin

| Re: | bioAffinity           
 Technologies, Inc.    
 Registration          
 Statement on Form S-1 
 Filed                 
 August 29, 2025       |
|:----|:----------------------|
|     | File                  
 No. 333-289944        |

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), bioAffinity Technologies, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:30 p.m., Eastern Time, on Tuesday, September 16, 2025, or as soon thereafter as possible.

Please notify Sean F. Reid of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 896-0610 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

| Very truly yours,              |                         |
| BIOAFFINITY TECHNOLOGIES, INC. |                         |
| By:                            | /s/                     
 Maria Zannes            |
| Name:                          | Maria Zannes            |
| Title:                         | Chief Executive Officer |